483
Centaur IncFDA 483 - Centaur Inc - February 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Centaur Inc. in Olathe, KS, a drug manufacturer, received a Form 483 citing significant quality control deficiencies during an FDA inspection from January 29 to February 1, 2024. The firm failed to thoroughly investigate out-of-specification water system results and lacked proper sampling procedures, impacting the quality assurance of multiple drug product batches.
Open in Dashboard
ID · ad3ae69d-3424-4d98-a687-f45ff54d122f